江化微(603078.SH):副董事長劉愛吉因病去世
格隆匯9月26日丨江化微(603078.SH)公佈,董事會沉痛公吿,近日公司獲悉副董事長劉愛吉先生因病去世。劉愛吉先生在任職公司董事、副董事長、董事會戰略委員會委員及審計委員會委員期間恪盡職守、勤勉盡責,認真履行了作為公司董事應盡的職責和義務,為公司的經營發展做出了重要貢獻。公司董事會對劉愛吉先生為公司的辛勤付出和貢獻深表感謝。公司董事、監事、高級管理人員及全體員工對劉愛吉先生的去世表示沉痛哀悼,並向其家屬表達深切慰問。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.